Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2003 Apr;31(8):695-700.
doi: 10.1038/sj.bmt.1703900.

Low mortality rates related to respiratory virus infections after bone marrow transplantation

Affiliations

Low mortality rates related to respiratory virus infections after bone marrow transplantation

C M Machado et al. Bone Marrow Transplant. 2003 Apr.

Abstract

Respiratory viruses (RVs) frequently cause severe respiratory disease in bone marrrow transplant (BMT) recipients. To evaluate the frequency of RV, nasal washes were collected year-round from BMT recipients with symptoms of upper respiratory tract infection (URI). Direct immunofluorescence assay was performed for respiratory syncytial virus (RSV), influenza (Flu) A and B, adenovirus and parainfluenza (Paraflu) virus. Patients with RSV pneumonia or with upper RSV infection, but considered at high risk for developing RSV pneumonia received aerosolized ribavirin. Oseltamivir was given to patients with influenza. A total of 179 patients had 392 episodes of URI. In all, 68 (38%) tested positive: RSV was detected in 18 patients (26.4%), Flu B in 17 (25%), Flu A in 11 (16.2%) and Paraflu in 7 (10.3%). A total of 14 patients (20.6%) had multiple RV infections or coinfection. RSV pneumonia developed in 55.5% of the patients with RSV-URI. One of the 15 patients (6.6%) with RSV pneumonia died. Influenza pneumonia was diagnosed in three patients (7.3%). RSV and influenza infections peaked in fall-winter and winter-spring months, respectively. We observed decreased rates of influenza and parainfluenza pneumonia and low mortality because of RSV pneumonia. The role of antiviral interventions such as aerosolized ribavirin and new neuraminidase inhibitors remains to be defined in randomized trials.

PubMed Disclaimer

Figures

Figure 1
Figure 1
RV infection in patients with respiratory symptoms according to the month of diagnosis.
Figure 2
Figure 2
Distribution of RV infection according to the month of diagnosis.

Similar articles

Cited by

References

    1. Whimbley E, Chaplin RE, Couch RB. Community respiratory virus infections among hospitalized adult bone marrow transplant recipients. Clin Infect Dis. 1996;22:778–792. doi: 10.1093/clinids/22.5.778. - DOI - PubMed
    1. Whimbley E, Englund J, Couch RB. Community respiratory virus infections in immunocompromised patients with cancer. Am J Med. 1997;102:10–18. doi: 10.1016/S0002-9343(97)80004-6. - DOI - PMC - PubMed
    1. Bowden RA. Respiratory virus infections after marrow transplant: the Fred Hutchinson Cancer Research Center experience. Am J Med. 1997;102:27–30. doi: 10.1016/S0002-9343(97)00007-7. - DOI - PubMed
    1. Englund J, Sullivan CJ, Jordan C. Respiratory syncytial virus infection in immunocompromised adults. Ann Int Med. 1988;109:203–208. doi: 10.7326/0003-4819-109-3-203. - DOI - PubMed
    1. Harrington RD, Hooton TM, Hackman RC. Na outbreak of respiratory syncytial virus in a bone marrow transplant center. J Infect Dis. 1992;165:987–993. doi: 10.1093/infdis/165.6.987. - DOI - PubMed

MeSH terms